logo
ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

527
Analysis
Health Care • South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Exchange Announcement • 23 Dec 2024 07:37

Material Business Matters Related to Investment Decisions(?????(CTP47, ???? ??????) ??(MFDS) ???? ??)

Exchange Announcement • 23 Dec 2024 07:37

Material Business Matters Related to Investment Decisions(ì•±í† ì¦ˆë§ˆì£¼(CTP47, ì• í œë¼ì£¼ 바이오시밀러) 한국(MFDS) 품목허가 획득)

Exchange Announcement • 18 Dec 2024 17:45

Material Business Matters Related to Investment Decisions(FDA approval of BLA for Steqeyma (CTP43, Stelara biosimilar))

Exchange Announcement • 18 Dec 2024 17:45

Material Business Matters Related to Investment Decisions(EMA approval of IND for CTP13 SC (Zymfentra) on rheumatoid arthritis patients (Part1&2))

Exchange Announcement • 18 Dec 2024 17:40

Decision on Acquisition of Shares or Investment Certificates of Other Corporation (Voluntary Disclosure)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x